MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$79,045K
(31.95%↑ Y/Y)
Income tax benefit
-$665K
(63.82%↑ Y/Y)
Net loss before
income taxes
-$79,710K
(32.45%↑ Y/Y)
Interest and other
income, net
$1,333K
(-58.60%↓ Y/Y)
Amtagvi
$60,222K
(38.22%↑ Y/Y)
Proleukin
$11,208K
(94.82%↑ Y/Y)
Loss from operations
-$81,043K
(33.14%↑ Y/Y)
Total revenue
$71,430K
Total costs and
expenses
$152,473K
(-10.60%↓ Y/Y)
Research and development
$62,487K
(-18.72%↓ Y/Y)
Cost of sales
$42,498K
(-14.56%↓ Y/Y)
Selling, general, and
administrative
$38,949K
(-11.33%↓ Y/Y)
Depreciation and
amortization
$8,539K
Back
Back
Income Statement
source: myfinsight.com
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)